Historique
Article de Périodique
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses [Viewpoint] (2017)
Auteur(s) :
LAZARUS, J. V. ;
SAFREED-HARMON, K. ;
STUMO, S. R. ;
JAUFFRET-ROUSTIDE, M. ;
MATICIC, M. ;
REIC, T. ;
SCHATZ, E. ;
TALLADA, J. ;
HARRIS, M. ;
HEP-CORE STUDY GROUP
Année
2017
Page(s) :
47-50
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
ACCES AUX SOINS
;
HEPATITE
;
ANTIVIRAUX
;
INJECTION
;
USAGER
Thésaurus géographique
EUROPE
Résumé :
In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a public health threat and established the ambitious targets of achieving an 80% reduction in new infections and a 65% reduction in deaths from hepatitis C virus (HCV) by 2030 (WHO, 2016a). The sharing of unsterile injecting equipment is a major driver of the European region's HCV epidemic (Hope, Eramova, Capurro, & Donoghoe, 2014; ECDC, 2015), and European countries are unlikely to reach the WHO targets unless they squarely address the HCV prevention, testing and treatment needs of people who inject drugs (PWID). [Extract]
Affiliation :
CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Cote :
Abonnement